Howard Gendelman, M.D.

Professor
University of Nebraska Medical Center

Poster(s):

• (M1030-06-36) Creating an Ultra-Long-Acting Parenteral Atovaquone Prodrug Nanosuspension for Malaria Chemoprophylaxis
  Monday, November 10, 2025

  10:30 AM - 11:30 AM CT

• (M1230-05-27) CCR5 Receptor Targeted Lipid Nanoparticles for HIV-1 Proviral DNA Excision
  Monday, November 10, 2025

  12:30 PM - 1:30 PM CT

• (M1230-07-42) Myeloid Targeted Disulfide Lipid Nanoparticle with Enhanced Endosomal Escape Improves HIV-1 Excision
  Monday, November 10, 2025

  12:30 PM - 1:30 PM CT

• (M1530-05-28) Piperazine Based Lipid Nanoparticles Facilitate Enhanced Endosomal Escape and CRISPR-Cas9 Mediated HIV-1 Proviral DNA Excision
  Monday, November 10, 2025

  3:30 PM - 4:30 PM CT